BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32250209)

  • 1. Pleural Effusion Due to Use of Pioglitazone: A Case Report.
    Xue J; Liu W; Shi F; Zheng J; Ma J
    Metab Syndr Relat Disord; 2020 Apr; 18(3):168-171. PubMed ID: 32250209
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive bilateral pleural effusion associated with use of pioglitazone.
    Chen YW; Chen YC; Wu CJ; Chen HH
    Clin Ther; 2008 Aug; 30(8):1485-9. PubMed ID: 18803990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between plasma hANP level and pretibial edema by pioglitazone treatment.
    Kahara T; Takamura T; Misaki T; Sakurai M; Takeshita Y; Shimizu A; Kaneko S
    Endocr J; 2005 Jun; 52(3):373-6. PubMed ID: 16006733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute progression of severe insulin edema accompanied by pericardial and pleural effusion in a patient with type 2 diabetes.
    Kawashima S; Kaneto H; Sakamoto K; Yasuda T; Kuroda A; Shiraiwa T; Yamamoto K; Kasami R; Matsuoka TA; Yamasaki Y; Matsuhisa M
    Diabetes Res Clin Pract; 2008 Aug; 81(2):e18-9. PubMed ID: 18502532
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.
    Mudaliar S; Chang AR; Henry RR
    Endocr Pract; 2003; 9(5):406-16. PubMed ID: 14583425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD; Parlan G; Bailey AL; Yee G; Yu M; Chan JY
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease].
    Chihara N; Hayakawa M; Yoshimura M; Shiio Y; Nakase H
    Rinsho Shinkeigaku; 2008 Feb; 48(2):143-5. PubMed ID: 18326310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A word of caution regarding pioglitazone.
    Usman MS; Rizwan T; Ahmed F
    J Pak Med Assoc; 2017 Jan; 67(1):153. PubMed ID: 28065979
    [No Abstract]   [Full Text] [Related]  

  • 9. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug.
    Nesti L; Tricò D; Mengozzi A; Natali A
    Cardiovasc Diabetol; 2021 May; 20(1):109. PubMed ID: 34006325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic pleural effusion due to gliclazide.
    Tzanakis N; Bouros D; Siafakas N
    Respir Med; 2000 Jan; 94(1):94. PubMed ID: 10714487
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case-control study.
    Woo MH; Lee HS; Kim J
    Cardiovasc Diabetol; 2019 May; 18(1):67. PubMed ID: 31151454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Kermani A; Garg A
    Mayo Clin Proc; 2003 Sep; 78(9):1088-91. PubMed ID: 12962163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.
    Liu CH; Lee TH; Lin YS; Sung PS; Wei YC; Li YR
    Cardiovasc Diabetol; 2020 Jan; 19(1):2. PubMed ID: 31910836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E
    Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis.
    Musso G; Cassader M; Paschetta E; Gambino R
    JAMA Intern Med; 2017 May; 177(5):633-640. PubMed ID: 28241279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones: the Forgotten Diabetes Medications.
    Lebovitz HE
    Curr Diab Rep; 2019 Nov; 19(12):151. PubMed ID: 31776781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pergolide-induced dyspnea, bilateral pleural effusion and peripheral edema.
    Varsano S; Gershman M; Hamaoui E
    Respiration; 2000; 67(5):580-2. PubMed ID: 11070468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pleural effusion and severe edema of the lower limbs induced by bromocriptine].
    Messiaen T; Lefebvre C; Weynand B; Pieters T
    Rev Med Interne; 1996; 17(8):680-3. PubMed ID: 8881198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory generalized edema: an infrequent complication of long-term pergolide treatment for Parkinson disease.
    Bianchi M; Castiglioni MG
    Clin Neuropharmacol; 2005; 28(5):245-6. PubMed ID: 16239767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone hydrochloride/glimepiride.
    Blake EW
    Drugs Today (Barc); 2007 Jul; 43(7):487-97. PubMed ID: 17728849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.